A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS). - Hasan, Hamza; Deek, Matthew P.; Phillips, Ryan; Hobbs, Robert F.; Malek, Reem; Radwan, Noura; Kiess, Ana P.; Dipasquale, Shirl; Huang, James; Caldwell, Terry; Leitzel, Jessica; Wendler, Danielle; et al. (BMC Cancer, 2020)